Naloxone-precipitated morphine withdrawal elicits increases in c-fos mRNA expression in restricted regions of the infant rat brain

Japanese Journal of Pharmacology

Volumn 90, Issue 3, 2002, Pages 270-275

  Maeda, Takehiko ^a   Kishioka, Shiroh ^a   Inoue, Norihiro ^a   Shimizu, Norifumi ^a   Fukazawa, Yohji ^a   Ozaki, Masanobu ^b   Yamamoto, Hiroyuki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

C fos mRNA; Infant rat; MK801; Morphine withdrawal; Naloxone

Indexed keywords

DIZOCILPINE; MESSENGER RNA; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; PROTEIN C FOS; NARCOTIC ANTAGONIST;

ADULT; ANIMAL EXPERIMENT; ANIMAL GENETICS; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; HYPOTHALAMUS; MALE; MEDULLA OBLONGATA; NONHUMAN; OLFACTORY BULB; PROVOCATION; RAT; WEIGHT REDUCTION; ANIMAL; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; MORPHINE ADDICTION; NEWBORN; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WITHDRAWAL SYNDROME;

ANIMALS; ANIMALS, NEWBORN; BRAIN; FEMALE; MALE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036857459     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.90.270     Document Type: Article

References (23)

1. Jones KL and Barr GA: Ontogeny of morphine withdrawal in the rat. Behav Neurosci 109, 1189-1198 (1995)
2. Strauss ME, Lessen-Firestone JK, Starr RH Jr and Ostrea EM Jr: Behavior of narcotics-addicted newborns. Child Development 46, 887-893 (1975)
3. Morgan JI, Cohen DR, Hempstead JL and Curran T: Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237, 192-197 (1987)
4. Hayward MD, Duman RS and Nestler EJ: Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res 525, 256-266 (1990)
5. Nye HB and Nestler EJ: Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol 49, 636-645 (1996)
6. Trujillo KA and Akil H: Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87 (1991)
7. Rasmussen K, Brodsky M and Inturrisi CE: NMDA antagonists and clonidine block c-fos expression during morphine withdrawal. Synapse 20, 68-74 (1995)
8. Curran T, Gordon MB, Rubino KL and Sambucetti LC: Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2, 79-84 (1987)
9. Fort P, Marty L, Piechaczyk M, El Sabrouty S, Dani C, Jeanteur P and Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acid Res 13, 1431-1442 (1985)
10. Apostolakos MJ, Schuermann WH, Frampton MW, Utell MJ and Willey JC: Measurement of gene expression by multiplex competitive polymerase chain reaction. Anal Biochem 213, 277-284 (1993)
11. Wang W and Dow KE: Quantitative analysis of mRNA expression of neuron-specific growth-associated genes in rat primary neurons by competitive RT-PCR. Brain Res Brain Res Protoc 2, 199-208 (1998)
12. Kishioka S, Inoue N, Nishida S, Fukunaga Y and Yamamoto H: Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats. Eur J Pharmacol 316, 7-14 (1996)
13. Schulz S, Schreff M, Koch T, Zimprich A, Gramsch C, Elde R and Hollt V: Immunolocalization of two F-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system. Neuroscience 82, 613-622 (1998)
14. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK and Nestler EJ: CREB (cAMP response element-binding protein) in the locus coeruleus: Biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17, 7890-7901 (1997)
15. Matsuoka I, Giuili G, Poyard M, Stengel D, Parma J, Guellaen G and Hanoune J: Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: Comparison with calmodulin mRNA distribution. J Neurosci 12, 3350-3360 (1992)
16. Couceyro P and Douglass J: Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain. Mol Pharmacol 47, 29-39 (1995)
17. Stornetta RL, Norton FE and Guyenet PG: Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res 624, 19-28 (1993)
18. Beckmann AM, Matsumoto I and Wilce PA: Immediate early gene expression during morphine withdrawal. Neuropharmacology 34, 1183-1189 (1995)
19. Monyer H, Burnashev N, Laurie DJ, Sakmann B and Seeburg PH: Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540 (1994)
20. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N and Nakanishi S: Molecular cloning and characterization of the rat NMDA receptor. Nature 354, 31-37 (1991)
21. Medvedev IO, Dravolina OA and Bespalov AY: Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm. J Pharmacol Exp Ther 286, 1260-1268 (1998)
22. Akera T and Brody TM: The addiction cycle to narcotics in the rat and its relation to catecholamines. Biochem Pharmacol 17, 675-688 (1968)
23. Wei B, Loh HH and Way EL: Quantitative aspects of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther 184, 398-403 (1973)